98955696 - CTX213

Information

• Trademark
• 98955696

• Source

• Serial Number

  98955696

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 13, 2025
  9 months ago

• Transaction Date

  July 24, 2025
  2 months ago

• Status Date

  July 16, 2025
  3 months ago

• Published for Opposition Date

  July 29, 2025
  2 months ago

• Location Date

  July 09, 2025
  3 months ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  SWAIN, MICHELE

• Attorney Docket Number

  33324/60093

  Attorney Name

  Tiffany D. Gehrke

  Law Office Assigned Location Code

  M70

• Owners

  • Crispr Therapeutics AG

Case File Statements

• PM0002: CTX TWO HUNDRED THIRTEEN
• GS0051: Cells for medical or clinical use in the field of stem cell therapy for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes; pharmaceutical and biopharmaceutical agents for the treatment of diabetes
• PM0001: CTX TWO ONE THREE
• GS0421: gene editing, namely, pharmaceutical research and development in the field of stem cell therapy for the treatment of diabetes; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of stem cell therapy for the treatment of diabetes

Case File Event Statements

• 1/13/2025 - 9 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/13/2025 - 9 months ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/10/2025 - 4 months ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/21/2025 - 3 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/24/2025 - 3 months ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/23/2025 - 2 months ago

  6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP